Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Evacuated residents of Oleshky arrive in Ukraine, Zelenskyy says
Rioters loot stores in Frankfurt as Gen Z-led protests in Germany turn violent
Congo Ebola outbreak kills more than 5,000
Isolated clashes in France, as tensions erupt after peaceful marches
